ORAL EPITHELIAL DYSPLASIA
Clinical trials for ORAL EPITHELIAL DYSPLASIA explained in plain language.
Never miss a new study
Get alerted when new ORAL EPITHELIAL DYSPLASIA trials appear
Sign up with your email to follow new studies for ORAL EPITHELIAL DYSPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to stop breast cancer before it starts
Disease control Not yet recruitingThis early-phase trial tests a drug called CAN1012 in 24 people with pre-cancerous breast conditions (DCIS or LCIS). The drug is injected directly into the lesion to activate the immune system. The main goal is to check safety and ensure the treatment doesn't delay necessary surg…
Matched conditions: ORAL EPITHELIAL DYSPLASIA
Phase: PHASE1 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Genetically modified cells injected into mouth lesions to stop cancer before it starts
Disease control Not yet recruitingThis early-phase trial tests whether specially engineered immune cells (NK cells) can safely treat high-risk precancerous spots in the mouth. The cells are injected directly into the lesions and are designed to target a protein called TROP2, while also resisting signals that norm…
Matched conditions: ORAL EPITHELIAL DYSPLASIA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC